The article “EULAR: Updated scleroderma guidance focuses on new treatments, approaches,” published June 23, 2015, misstated the recommendation given for glucocorticoid use in scleroderma renal crisis. The article should have said that the recommendations continue to advise against using glucocorticoids in this patient population, based on retrospective study data.

Ads

You May Also Like

Bleeding episodes more common in boys with VWD

REPORTING FROM THSNA 2018 SAN DIEGO (FRONTLINE MEDICAL NEWS) – Among children with types ...

Avoiding disillusionment

The holiday season, despite the hustle and bustle, can be a time of reflection. ...

Restoring the promise of (really) meaningful use

When we started publishing the EHR Report several years ago, our very first column ...